Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Method for Screening Delta Opioid Receptor Modulators


技術應用

The receptor may be used as a diagnostic tool for conditions involving opioid receptors. The invention provides a screen against recombinant receptor agonists and antagonists. The invention provides a negative screen to verify if drugs are truly selective to the delta opioid receptor. The opioid receptor can be prepared using standard peptide synthesis methods.


詳細技術說明

Researchers in the laboratory of Dr. Christopher Evans have cloned and characterized the delta opioid receptor. The present invention utilizes a cell based assay to detect the levels of activation of opioid receptors in the presence or absence of candidate drugs. The present invention provides methods for screening agonists and antagonists of the delta opioid receptor, and can potentially play a large role in the development of targeted therapies directed to treat a host of ailments. .


附加資料

Patent Number: US6265563B1
Application Number: US1995387707A
Inventor: Evans, Christopher J. | Keith, Duane E. | Edwards, Robert H. | Kaufman, Daniel
Priority Date: 13 Aug 1992
Priority Number: US6265563B1
Application Date: 13 Feb 1995
Publication Date: 24 Jul 2001
IPC Current: G01N003353 | A61K00317088 | A61K0039395 | A61K004500 | A61K004800 | A61P002504 | C07H002104 | C07K0014705 | C07K001472 | C12N000115 | C12N000119 | C12N000121 | C12N000510 | C12N001509 | C12N001512 | C12P002102 | C12P002104 | C12P002108 | C12Q000102
US Class: 5360235 | 4350691 | 4350701 | 4350711 | 4350712 | 4352523 | 43525411 | 4353201 | 435325 | 435365 | 435475 | 4352402
Assignee Applicant: The Regents of the University of California
Title: Opioid receptor genes
Usefulness: Opioid receptor genes
Summary: The nucleic acids may be used to recombinantly express kappa and mu opioid receptors in host cells. These cells may then be used in assays to identify modulators of the receptors activity that may be used, for example as analgesics or to combat the effects of opioid addiction. The nucleic acids and their complements may also be used as probe sequences to identify and characterize opioid receptor nucleic acids.
Novelty: Nucleic acids encoding mammalian kappa and mu opioid receptors, useful e.g. to identify substances for treating opioid addiction and/or useful as analgesics


主要類別

生物醫學


細分類別

DNA /基因工程


申請號碼

6265563


其他

Background

Opioid receptors are abundant in the central and peripheral nervous system and are the targets of both opiate drugs and a family of endogenous opioid peptides. Seminal work carried out by Dr. Evans' research group at UCLA on this receptor has led to key insights in the field of neuropharmacology. To date, the delta opioid receptor has been implicated in various diseases including, but not limited to, pain, depression, neuroprotection, drug abuse and impulse control disorders. Moreover, on-going work has hinted at additional roles for this critical receptor. A method for screening potential modulators of the delta opioid receptors would provide unparalleled insight into the development of targeted therapies against this key target.

Additional Technologies by these Inventors


Tech ID/UC Case

22617/1993-576-0


Related Cases

1993-576-0


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版